# Detoxification From the Lipid Tract

> **NCT06357104** · PHASE4 · COMPLETED · sponsor: **Pachankis, Yang I., M.D.** · enrollment: 1 (actual)

## Conditions studied

- COVID-19 Vaccine Adverse Reaction

## Interventions

- **DEVICE:** electroencephalogram biofeedback
- **DEVICE:** electrical brain stimulation
- **DEVICE:** ultra-low frequency transcranial magnetic stimulation
- **DRUG:** Sertraline Hydrochloride
- **DRUG:** Clonazepam
- **DRUG:** Alprazolam
- **DRUG:** Metoprolol
- **DRUG:** Olanzapine
- **DRUG:** Pravastatin Sodium 20 MG
- **DRUG:** Sacubitril Valsartan Sodium Hydrate

## Key facts

- **NCT ID:** NCT06357104
- **Lead sponsor:** Pachankis, Yang I., M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-26
- **Primary completion:** 2024-03-14
- **Final completion:** 2024-03-20
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2024-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06357104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06357104, "Detoxification From the Lipid Tract". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06357104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*